Related references
Note: Only part of the references are listed.Divergent results induced by different types of septic shock in transglutaminase 2 knockout mice
Hyun Yoo et al.
AMINO ACIDS (2013)
Solid-Phase Parallel Synthesis of Drug-Like Artificial 2H-Benzopyran Libraries
Taeho Lee et al.
MOLECULES (2012)
TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2
Mireille Delhase et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A novel 3-arylethynyl-substituted pyrido[2,3,-b]pyrazine derivatives and pharmacophore model as Wnt2/β-catenin pathway inhibitors in non-small-cell lung cancer cell lines
Young-Dae Gong et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Role of tissue transglutaminase 2 in the acquisition of a mesenchymal-like phenotype in highly invasive A431 tumor cells
Chun-Yu Lin et al.
MOLECULAR CANCER (2011)
Blockade of enzyme activity inhibits tissue transglutaminase-mediated transamidation of α-synuclein in a cellular model of Parkinson's disease
Robin Verhaar et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
A new paradigm for cancer therapeutics development
Soo-Youl Kim
BMB REPORTS (2010)
Potential of transglutaminase 2 as a therapeutic target
Daniela Caccamo et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Inhibition of tissue transglutaminase sensitizes TRAIL-resistant lung cancer cells through upregulation of death receptor 5
Manuela Frese-Schaper et al.
FEBS LETTERS (2010)
Combinatorial Syntheses of Five-Membered Ring Heterocycles Using Carbon Disulfide and a Solid Support
Young-Dae Gong et al.
JOURNAL OF COMBINATORIAL CHEMISTRY (2010)
Tissue transglutaminase 2 as a biomarker of cervical intraepithelial neoplasia (CIN) and its relationship to p16(INK4A) and nuclear factor kappa B expression
Ruchi Gupta et al.
VIRCHOWS ARCHIV (2010)
Glucosamine is an effective chemo-sensitizer via transglutaminase 2 inhibition
Dae-Seok Kim et al.
CANCER LETTERS (2009)
Epithelial-to-Mesenchymal Transition and Ovarian Tumor Progression Induced by Tissue Transglutaminase
Minghai Shao et al.
CANCER RESEARCH (2009)
Silencing of TGase 2 sensitizes breast cancer cells to apoptosis by regulation of survival factors
Dae-Seok Kim et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Transglutaminases and Disease: Lessons From Genetically Engineered Mouse Models and Inherited Disorders
Siiri E. Iismaa et al.
PHYSIOLOGICAL REVIEWS (2009)
Synthesis of potent water-soluble tissue transglutaminase inhibitors
Martin Griffin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Identification of Chemical Inhibitors to Human Tissue Transglutaminase by Screening Existing Drug Libraries
Thung-S. Lai et al.
CHEMISTRY & BIOLOGY (2008)
Cinnamoyl inhibitors of tissue transglutaminase
Christophe Pardin et al.
JOURNAL OF ORGANIC CHEMISTRY (2008)
Structure-based design of α-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2
Matthew Siegel et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Transglutaminase 2 inhibitors and their therapeutic role in disease states
Matthew Siegel et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy
L. Yuan et al.
ONCOGENE (2007)
Transglutaminase-mediated activation of nuclear transcription Factor-kappa B in cancer cells: A new therapeutic opportunity
Amit Verma et al.
CURRENT CANCER DRUG TARGETS (2007)
Transglutaminase 2 mediates polymer formation of I-κBα through C-terminal glutamine cluster
Sung-Soo Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-κB inactivation
Dae-Seok Kim et al.
CANCER RESEARCH (2006)
The NCI60 human tumour cell line anticancer drug screen
Robert H. Shoemaker
NATURE REVIEWS CANCER (2006)
Transglutaminase 2 in inflammation
Soo-Youl Kim
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-κB in cancer cells:: Delineation of a novel pathway
Aman P. Mann et al.
CANCER RESEARCH (2006)
Chemistry and biology of dihydroisoxazole derivatives: Selective inhibitors of human transglutaminase 2
K Choi et al.
CHEMISTRY & BIOLOGY (2005)
Transglutaminase 2 induces nuclear factor-κB activation via a novel pathway in BV-2 microglia
JM Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Transglutaminases: Crosslinking enzymes with pleiotropic functions
L Lorand et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis
J Sohn et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)